Products & Ingredients

Instytutum Launches NMN Supplement, At-Home Biological Age Test

The longevity supplement contains 500 mg of liposomal NMN and 500 mg of micronized trans-resveratrol to support NAD+, cellular energy, and more.

Author Image

By: Mike Montemarano

Associate Editor, Nutraceuticals World

Photo: Instytutum

Longevity brand Instytutum has launched a formula featuring liposomal NMN and micronized trans-resveratrol developed by a team of scientists led by Natalia Bobok, PhD, a scientist specializing in longevity and founder of the brand.

The supplement is formulated to support NAD+ levels, cellular energy, mental clarity, physical performance, metabolic health, and beauty from within.

NAD+ is a molecule essential to cellular energy production, DNA repair, and longevity, and declines naturally with age. NMN is a precursor to support NAD+ synthesis pathways. While standard NMN ingredients are partially broken down in the digestive tract before reaching cells, the company’s liposomal encapsulation delivers NMN intact, reportedly absorbed at a 60% greater rate. The company also reports that supplementation for four weeks results in an 84% increase in blood concentrations of NAD+.

The Instytutum Biological Age Test is an at-home epigenetic saliva test used to determine biological markers of age. It is intended to be used before and after supplementation, helping to track the effects of the longevity supplement.

“Longevity has moved from elite clinics into daily life,” said Bobok. “The future of beauty will not be built around masking visible signs of aging, but around influencing the root causes and reducing biological age at the cellular level. Consumers are no longer asking how to look younger. They are asking how to extend their healthspan, the years of life lived with energy, resilience, and vitality. Our mission is to simplify and accelerate the path to beauty and longevity, making it accessible to everyone, not just a privileged few.”

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters